DOI: 10.36347/sjams.2020.v08i03.037

Pages: 996-1000

Hepatitis C virus and Hepatitis B virus are the most important infections transmitted in Hemodialysis patients. HBV and HCV are the major cause of liver diseases in these patients. These infections lead to serious complications like cirrhosis and hepatocellular carcinoma. Hence the present study was done to determine the seroprevalence of HCVand HBV in chronic renal failure patients undergoing Hemodialysis. The study was a prospective study conducted over a period of 1 year from 2018-2019 in Chronic Renal failure patients undergoing Hemodialysis. A total of 60 serum and plasma samples were collected and tested for HBV by HBsAg ELISA, HCV by Anti HCV ELISA, HCV RNA by HCV RT PCR. All the patients were seronegative for HBsAg. Anti HCV antibodies were detected in 13(21.66%) patients. HCV RNA was detected in 25(41.66%) patients.To conclude Hemodialyis patients are at risk of acquiring blood borne viral infections like HBV and HCV. Prevention and adherence to universal precautions are the main factors for the control of these blood borne viral infections. Hence use of dedicated dialysis machines, screening of patients for Blood borne viral infections for every 3 months and training of staff is recommended to reduce the risk of complications in these patients.